Resonance Health Ltd has released a press release.
US FDA Clearance for LiverSmart
Filed with ASX ·
6ix hasn’t read this filing yet.
Story so far
Earlier from Resonance Health
- ASO Project New Data
- LiverSmart Submitted to FDA for US Regulatory Clearance
- Investor Presentation - Positioning for Growth
- ASO R&D Project - Filing of Two Patent Applications
- Thalassaemia International Federation to Deploy FerriSmart
Later from Resonance Health
- Resonance Health Contracted for Third Party Clinical Trial
- Resonance Health Enters China - Pharma Contract Signed
- US CPT Code Confirmation for LiverSmart
- Platform Integration & Partnership Agreement with CARPL.ai
- Quarterly Activities/Appendix 4C Cash Flow Report
Follow Resonance Health into a list and get an email when it puts out news.
Follow Resonance Health